Advanced search
Publication Cover
HIV Clinical Trials Volume 17, 2016 - Issue 5
Submit an article Journal homepage
333
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Long-term follow-up of HIV seroconverters in microbicide trials – rationale, study design, and challenges in MTN-015

Sharon A. RiddlerDivision of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USACorrespondence[email protected]
,
Marla HusnikMTN Statistical and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
,
Pamina M. GorbachDepartment of Epidemiology, University of California, Los Angeles, CA, USA
,
Lisa LevyFHI360, Durham, NC, USA
,
Urvi ParikhDivision of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA
,
Edward LivantMicrobicide Trials Network, Magee-Womens Research Institute, Pittsburgh, PA, USA
,
Arendevi PatherHIV Prevention Research Unit, South African Medical Research Council, Durban, South Africa
,
Bonus MakananiCollege of Medicine-John Hopkins University Research Project, Queen Elizabeth Central Hospital, Blantyre, Malawi
,
Felix MuhlangaUZ-UCSF Collaborative Research Programme, University of Zimbabwe, Harare, Zimbabwe
,
Margaret KasaroCentre for Infectious Disease Research in Zambia, Lusaka, Zambia
,
Francis MartinsonUNC Project – Tidziwe Centre, Kamuzu Central Hospital, Lilongwe, Malawi
,
Vanessa ElharrarDivision of AIDS, National Institutes of Health, Bethesda, MD, USA
,
Jennifer E. BalkusMTN Statistical and Data Management Center, Fred Hutchinson Cancer Research Center, Seattle, WA, USA
& on Behalf of the MTN-015 Protocol Team for the Microbicide Trials Network show all
Pages 204-211 | Published online: 28 Jul 2016

References

  • Etter P, Landovitz R, Sibeko S, et al. Recommendations for the follow-up of study participants with breakthrough HIV infections during HIV/AIDS biomedical prevention studies. AIDS. 2013;27(7):1119–1128.10.1097/QAD.0b013e32835dc08e
  • Garrett NJ, Werner L, Naicker N, et al. HIV disease progression in seroconvertors from the CAPRISA 004 Tenofovir gel pre-exposure prophylaxis trial. J Acquir Immune Defic Syndr. 2015;68(1):55–61.10.1097/QAI.0000000000000367
  • Kersh EN, Luo W, Zheng Q, et al. Reduced inflammation and CD4 loss in acute SHIV infection during oral pre-exposure prophylaxis. J Infect Dis. 2012;206(5):770–779.10.1093/infdis/jis422
  • Baeten JM, Donnell D, Ndase P, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399–410.10.1056/NEJMoa1108524
  • Grant RM, Lama JR, Anderson PL, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587–2599.10.1056/NEJMoa1011205
  • Grant RM, Liegler T, Defechereux P, et al. Drug resistance and plasma viral RNA level after ineffective use of oral pre-exposure prophylaxis in women. AIDS. 2015;29(3):331–337.10.1097/QAD.0000000000000556
  • Liegler T, Abdel-Mohsen M, Bentley LG, et al. HIV-1 drug resistance in the iPrEx preexposure prophylaxis trial. J Infect Dis. 2014;210(8):1217–1227.10.1093/infdis/jiu233
  • Thigpen MC, Kebaabetswe PM, Paxton LA, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423–434.10.1056/NEJMoa1110711
  • Marrazzo JM, Ramjee G, Richardson BA, et al. Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015;372(6):509–518.10.1056/NEJMoa1402269
  • Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science. 2010;329(5996):1168–1174.10.1126/science.1193748
  • Wei X, Hunt G, Abdool Karim SS, et al. Sensitive tenofovir resistance screening of HIV-1 from the genital and blood compartments of women with breakthrough infections in the CAPRISA 004 tenofovir gel trial. J Infect Dis. 2014;209(12):1916–1920.10.1093/infdis/jiu026
  • Abdool Karim SS, Richardson BA, Ramjee G, et al. Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS. 2011;25(7):957–966.10.1097/QAD.0b013e32834541d9
  • Penrose KJ, Parikh UM, Hamanishi KA, et al. Selection of Rilpivirine-resistant HIV-1 in a seroconverter from the SSAT 040 trial who received the 300-mg dose of long-acting Rilpivirine (TMC278LA). J Infect. Dis. 2016;213:1013–1017.
  • Hesbacher PT, Rickels K, Morris RJ, et al. Psychiatric illness in family practice. J Clin Psychiatry. 1980;41(1):6–10.
  • Kaaya SF, Fawzi MC, Mbwambo JK, et al. Validity of the Hopkins symptom checklist-25 amongst HIV-positive pregnant women in Tanzania. Acta Psychiatr Scand. 2002;106(1):9–19.
  • World Health Organization. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children; 2007. Available from: www.who.int/hiv/pub/guidelines/HIVstaging150307.pdf
  • Palanee-Phillips T, Schwartz K, Brown ER, et al. Characteristics of women enrolled into a randomized clinical trial of dapivirine vaginal ring for HIV-1 prevention. PLos One. 2015;10(6):e0128857.10.1371/journal.pone.0128857
  • Naik R, Doherty T, Jackson D, et al. Linkage to care following a home-based HIV counselling and testing intervention in rural South Africa. J Int AIDS Soc. 2015;18:19843.
  • Turan B, Stringer KL, Onono M, et al. Linkage to HIV care, postpartum depression, and HIV-related stigma in newly diagnosed pregnant women living with HIV in Kenya: a longitudinal observational study. BMC Pregnancy Childbirth. 2014;14:1–10.10.1186/s12884-014-0400-4
  • McKenney JL. Behavior change and other factors related to HIV transmission among female sero-converters in microbicide trials. Epidemiology, University of California Los Angeles; 2015. Available from: http://escholarship.org/uc/item/7kj8z5wc
  • Antelman G, Kaaya S, Wei R, et al. Depressive symptoms increase risk of HIV disease progression and mortality among women in Tanzania. J Acquir Immune Defic Syndr. 2007;44(4):470–477.10.1097/QAI.0b013e31802f1318
  • Gorbach PM, Mensch BS, Husnik M, et al. Effect of computer-assisted interviewing on self-reported sexual behavior data in a microbicide clinical trial. AIDS Behav. 2013;17(2):790–800.10.1007/s10461-012-0302-2

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.